What is “Riomet” and which patent protections matter?
Riomet is the brand name for metformin hydrochloride oral solution. Patent “watch” tracking usually focuses on the patents that protect the active ingredient formulation, manufacturing process, and any related exclusivity that could delay generic or other competitors from marketing an equivalent product. With only the question provided, I can’t identify the specific Riomet patent numbers or their exact expiry dates.
How to set up a Riomet patent watch (what to monitor)
A useful patent-watch checklist for Riomet typically tracks:
- Patent applications and grants to the drug product and its formulation/device/manufacturing claims (not just the basic drug substance).
- Later-life changes (new patents on different strengths, liquid formulations, stability or bioavailability improvements, or manufacturing improvements).
- Any legal events involving those patents (e.g., challenges that lead to settlement dates).
- Regulatory exclusivity that can affect approval timing even when patents expire.
Where patent-watch data usually comes from
To build a reliable Riomet patent watch, you’d typically pull from:
- FDA Orange Book listings for Riomet (lists approved drug products and associated patents/exclusivities).
- Federal court dockets and settlement announcements tied to generic challenges.
- USPTO records for new filings and continuation activity.
Can a Riomet “patent watch” be answered with exact dates?
Exact patent expiry for Riomet depends on the specific patent(s) listed for the product in the Orange Book (and whether they are listed with a “delist” date or tied to a specific route/strength). Without the Orange Book entry (or at least the Riomet strength and dosage form), I can’t give accurate expiry dates.
If you share one detail, I can pinpoint the patents to watch
If you tell me either:
- the exact FDA product identifier for Riomet you mean (strength is often needed), or
- the URL/text of the Riomet Orange Book entry,
I can list the specific patents and their status (including expected expiry) and summarize what events would move the watch (grants, delistings, litigation outcomes).
Sources needed to answer “Riomet patent watch” precisely
To produce an accurate patent watch, I need access to the Orange Book “patent list” for Riomet (or the specific patent numbers you want monitored). If you paste that information here, I’ll turn it into a clean watch table with what matters and what dates to track.
What competitors are likely watching alongside Riomet patents
Generic and authorized-competitor filings often align with:
- When key Orange Book patents expire (or are declared not infringed).
- Any “gut check” exclusivities that can extend market protection.
- Whether new Riomet-specific formulation or process patents get granted during the watch period.
Quick question to tailor the watch
Which Riomet do you mean (strength and dosage form, e.g., Riomet (metformin HCl) oral solution, and the specific strength listed on the Orange Book)?